<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00571428</url>
  </required_header>
  <id_info>
    <org_study_id>091-903</org_study_id>
    <nct_id>NCT00571428</nct_id>
  </id_info>
  <brief_title>Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD</brief_title>
  <official_title>Modified-blind, Randomized, Multicenter, Single Dose, Two-way Crossover Study of Arformoterol Tartrate Inhalation Solution 15 Micrograms Twice A Day Versus 30 Micrograms Once A Day in Subjects With Chronic Obstructive Pulmonary Disease (COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunovion</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunovion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of arformoterol tartrate inhalation solution 30μg/4mL QD
      (two 15μg/2mL dosed in combination) over a 24-hour period compared to arformoterol tartrate
      inhalation solution 15μg/2 mL BID in subjects with COPD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a modified blind, randomized, multicenter, single dose two-way crossover study to
      assess the efficacy and safety of arformoterol 15μg BID versus arformoterol 30μg QD in
      subjects with COPD. Subject participation will last approximately three weeks and will
      include a screening visit, two 24-hour visits, and a follow up telephone call. This study was
      previously posted by Sepracor Inc. In October 2009, Sepracor Inc. was acquired by Dainippon
      Sumitomo Pharma., and in October 2010, Sepracor Inc's name was changed to Sunovion
      Pharmaceuticals Inc.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 24 Hours</measure>
    <time_frame>0-24 hours post dose</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 24 hours of dosing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 12 Hours</measure>
    <time_frame>0-12 hours</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 12 hours of dosing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Between 12-24 Hours</measure>
    <time_frame>12-24 hours</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken between 12 and 24 hours of dosing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Forced Expiratory Volume in One Second From Pre-dose to the 24 Hour Time Point</measure>
    <time_frame>pre-dose and 24 hours post-dose</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 24 hours post-dose, which represents the trough in dose level.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced Expiratory Volume in One Second Measurements Pre-dose and at Each Assessed Time Point Post-dose</measure>
    <time_frame>pre-dose, immediately post-dose, 30 min, 1,2,4,6,8,10,12, 12.5,13,14,16,23,24 hours post first dose</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the FEV1 readings taken pre-dose and at various time points within 24 hours post-dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Forced Expiratory Volume in One Second From Pre-dose To Each Assessed Time Point Post-Dose</measure>
    <time_frame>Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the change in FEV1 readings between pre-dose and various time points within 24 hours post-dose.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of Predicted Forced Expiratory Volume at One Second at Pre-dose and Each Assessed Time Point Post-Dose</measure>
    <time_frame>Pre-dose, Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
    <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function at specified time points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Percent of Predicted Forced Expiratory Volume at One Second (FEV1) at Each Assessed Time Point Post-Dose Compared to Pre-Dose</measure>
    <time_frame>Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
    <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the change in percent of the estimated healthy lung function at specified time points compared to the pre-dose value.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Percent of Predicted Forced Expiratory Volume at One Second (FEV1) Over 12 Hours Post-Dose.</measure>
    <time_frame>12 hours</time_frame>
    <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function and reports the highest percent found within 12 hours of dosing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peak Change in Forced Expiratory Volume at One Second (FEV1) Within 12 Hours Post Dose Compared to Pre-dose</measure>
    <time_frame>12 hours</time_frame>
    <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 12 hours post-dose, and reports the largest change during that time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Onset of 15 Percent Response Within 12 Hours of Dosing</measure>
    <time_frame>12 hours post first dose</time_frame>
    <description>Time to a 15 percent improvement in forced expiratory volume in one second (FEV1) within 12 hours of dosing. Only patients who achieved at least a 15 percent improvement are included.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase Within 12 Hours of Dosing</measure>
    <time_frame>up to 12 hours post dose</time_frame>
    <description>Time to a 12 percent improvement in forced expiratory volume in one second (FEV1) AND a 200 milliliter increase in FEV1 within 12 hours of dosing. Only patients who met both conditions are included</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase in Forced Expiratory Volume in One Second Within 12 Hours of Dosing</measure>
    <time_frame>pre-dose, immediately post first dose, 30 min, 1,2,4,6,8,10,12, 12.5, 13, 14, 16, 23,24 hours post first dose</time_frame>
    <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Forced Vital Capacity From Pre-dose to Each Post-Dose Assessed Time Point</measure>
    <time_frame>immediately post first dose, 30 min, 1,2,4,6,8,10,12, 12.5, 13, 14, 16, 23,24 hours post first dose</time_frame>
    <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration. The measure compares the change from pre-dose reading to each post-dose time point.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>15 mcg BID / 30 mcg QD</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arformoterol 15 microgram twice a day (BID) taken each morning and evening for one visit followed by Arformoterol 30 microgram once a day (QD) in the morning and placebo in the evening for the next visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>30 mcg QD / 15 mcg BID</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arformoterol 30 microgram once a day (QD) in the morning and placebo in the evening for one visit followed by Arformoterol 15 microgram twice a day (BID) in the morning and evening for the next visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arformoterol Tartrate Inhalation Solution</intervention_name>
    <description>Nebulized arformoterol tartrate inhalation solution 15 microgram twice a day (BID)</description>
    <arm_group_label>15 mcg BID / 30 mcg QD</arm_group_label>
    <arm_group_label>30 mcg QD / 15 mcg BID</arm_group_label>
    <other_name>Brovana</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Arformoterol Tartrate Inhalation Solution</intervention_name>
    <description>Nebulized arformoterol tartrate inhalation solution 30 microgram once a day (QD)</description>
    <arm_group_label>15 mcg BID / 30 mcg QD</arm_group_label>
    <arm_group_label>30 mcg QD / 15 mcg BID</arm_group_label>
    <other_name>Brovana</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo inhalation solution (citrate buffered 0.9% saline solution) once a day</description>
    <arm_group_label>15 mcg BID / 30 mcg QD</arm_group_label>
    <arm_group_label>30 mcg QD / 15 mcg BID</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female subjects must be at least 45 years old at the time of consent.

          -  Subjects must have a pre-established primary clinical diagnosis of COPD.

          -  Subjects must have a baseline FEV1 of ≤ 65% of predicted normal value at Visit 1.

          -  Subjects must have a FEV1 ≥ 0.70L at Visit 1.

          -  Subjects must have a FEV1/forced vital capacity (FVC) ratio of ≤ 70% at Visit 1.

        Exclusion Criteria:

          -  Subjects who do not have a 15 pack-year smoking history and a baseline breathlessness
             severity grade of 2 (as measured by the Modified Medical Research Council [MMRC]
             Dyspnea Scale Score) at Screening.

          -  Subjects with life-threatening/unstable respiratory status, including upper or lower
             respiratory tract infection, within the previous 30 days prior to Visit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pulmonary Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sunovion</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Medford</city>
        <state>Oregon</state>
        <zip>97504</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spartanburg</city>
        <state>South Carolina</state>
        <zip>29303</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2007</study_first_submitted>
  <study_first_submitted_qc>December 10, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2007</study_first_posted>
  <results_first_submitted>March 13, 2009</results_first_submitted>
  <results_first_submitted_qc>May 12, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 2, 2009</results_first_posted>
  <last_update_submitted>February 21, 2012</last_update_submitted>
  <last_update_submitted_qc>February 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Chronic Bronchitis</keyword>
  <keyword>Emphysema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Formoterol Fumarate</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>15 Mcg BID / 30 Mcg QD</title>
          <description>Arformoterol 15 mcg twice a day (morning and evening) for one visit followed by Arformoterol 30 mcg once a day (morning) and placebo (evening) for the next visit.</description>
        </group>
        <group group_id="P2">
          <title>30 Mcg QD / 15 Mcg BID</title>
          <description>Arformoterol 30 mcg once a day (morning) and placebo (evening) for one visit followed by Arformoterol 15 mcg twice a day (morning and evening) for the next visit.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>15 Mcg BID / 30 Mcg QD</title>
          <description>Arformoterol 15 mcg twice a day (morning and evening) for one visit followed by Arformoterol 30 mcg once a day (morning) and placebo (evening) for the next visit.</description>
        </group>
        <group group_id="B2">
          <title>30 Mcg QD / 15 Mcg BID</title>
          <description>Arformoterol 30 mcg once a day (morning) and placebo (evening) for one visit followed by Arformoterol 15 mcg twice a day (morning and evening) for the next visit.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="33"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="19.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.9" spread="9.3"/>
                    <measurement group_id="B2" value="64.9" spread="8.7"/>
                    <measurement group_id="B3" value="64.5" spread="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="29.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Inhaled Corticosteroid Use at Baseline</title>
          <description>This measure answers the question: Does the patient use a corticosteroid inhaler at the baseline visit?</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Yes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Participants Categorized by the Number of Pack Years Smoked</title>
          <description>Pack years smoked is a way to measure the amount a person has smoked over a long period of time. It is calculated by taking the number of cigarettes smoked per day times the the number of years smoked divided by 20 (cigarettes per pack).</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;=15 years - &lt;25 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=25 years - &lt; 30 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=30 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="27.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Participants Categorized by the Number of Packs Currently Smoked per Day</title>
          <description>This measure gives an indication of the quantity of cigarettes currently smoked per day.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&gt;0 -1 pack</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;1 -2 packs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;2 - 4 packs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 4 packs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Currently does not smoke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="18.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 24 Hours</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 24 hours of dosing.</description>
        <time_frame>0-24 hours post dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 24 Hours</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 24 hours of dosing.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.156" spread="0.156"/>
                    <measurement group_id="O2" value="0.173" spread="0.183"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence was defined a priori such that 90%CI for the difference between therapies had to fall entirely within +/- 0.07L.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.011</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>-0.015</ci_lower_limit>
            <ci_upper_limit>0.037</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 12 Hours</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 12 hours of dosing.</description>
        <time_frame>0-12 hours</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Over 12 Hours</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken within 12 hours of dosing.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.148" spread="0.152"/>
                    <measurement group_id="O2" value="0.214" spread="0.163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence was defined a priori such that 90%CI for the difference between therapies has to fall entirely within +/- 0.07L.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.062</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>0.035</ci_lower_limit>
            <ci_upper_limit>0.090</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Between 12-24 Hours</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken between 12 and 24 hours of dosing.</description>
        <time_frame>12-24 hours</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time-Normalized Area Under the Change From Pre-Dose Curve for Forced Expiratory Volume in One Second Measured Between 12-24 Hours</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change from pre-dose for a series of FEV1 readings taken between 12 and 24 hours of dosing.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.179" spread="0.154"/>
                    <measurement group_id="O2" value="0.132" spread="0.211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence was defined a priori such that 90%CI for the difference between therapies has to fall entirely within +/- 0.07L.</non_inferiority_desc>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-0.035</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>-0.079</ci_lower_limit>
            <ci_upper_limit>0.008</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Forced Expiratory Volume in One Second From Pre-dose to the 24 Hour Time Point</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 24 hours post-dose, which represents the trough in dose level.</description>
        <time_frame>pre-dose and 24 hours post-dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Forced Expiratory Volume in One Second From Pre-dose to the 24 Hour Time Point</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 24 hours post-dose, which represents the trough in dose level.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.144" spread="0.161"/>
                    <measurement group_id="O2" value="0.120" spread="0.195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence was defined a priori such that 90%CI for the difference between therapies has to fall entirely within +/- 0.07L.</non_inferiority_desc>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-0.030</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>-0.086</ci_lower_limit>
            <ci_upper_limit>0.026</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Forced Expiratory Volume in One Second Measurements Pre-dose and at Each Assessed Time Point Post-dose</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the FEV1 readings taken pre-dose and at various time points within 24 hours post-dose.</description>
        <time_frame>pre-dose, immediately post-dose, 30 min, 1,2,4,6,8,10,12, 12.5,13,14,16,23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Forced Expiratory Volume in One Second Measurements Pre-dose and at Each Assessed Time Point Post-dose</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the FEV1 readings taken pre-dose and at various time points within 24 hours post-dose.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.184" spread="0.366"/>
                    <measurement group_id="O2" value="1.179" spread="0.342"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immediately post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.332" spread="0.418"/>
                    <measurement group_id="O2" value="1.358" spread="0.386"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.349" spread="0.392"/>
                    <measurement group_id="O2" value="1.384" spread="0.374"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.362" spread="0.387"/>
                    <measurement group_id="O2" value="1.401" spread="0.394"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.378" spread="0.375"/>
                    <measurement group_id="O2" value="1.419" spread="0.378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.342" spread="0.374"/>
                    <measurement group_id="O2" value="1.429" spread="0.375"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.359" spread="0.426"/>
                    <measurement group_id="O2" value="1.414" spread="0.384"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.303" spread="0.402"/>
                    <measurement group_id="O2" value="1.373" spread="0.397"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=31,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.308" spread="0.371"/>
                    <measurement group_id="O2" value="1.371" spread="0.411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.270" spread="0.365"/>
                    <measurement group_id="O2" value="1.327" spread="0.400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.359" spread="0.359"/>
                    <measurement group_id="O2" value="1.332" spread="0.409"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.389" spread="0.375"/>
                    <measurement group_id="O2" value="1.330" spread="0.378"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.397" spread="0.389"/>
                    <measurement group_id="O2" value="1.337" spread="0.411"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.368" spread="0.357"/>
                    <measurement group_id="O2" value="1.344" spread="0.420"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.297" spread="0.373"/>
                    <measurement group_id="O2" value="1.252" spread="0.412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.296" spread="0.363"/>
                    <measurement group_id="O2" value="1.279" spread="0.417"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Forced Expiratory Volume in One Second From Pre-dose To Each Assessed Time Point Post-Dose</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the change in FEV1 readings between pre-dose and various time points within 24 hours post-dose.</description>
        <time_frame>Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Forced Expiratory Volume in One Second From Pre-dose To Each Assessed Time Point Post-Dose</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome offers the change in FEV1 readings between pre-dose and various time points within 24 hours post-dose.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.148" spread="0.109"/>
                    <measurement group_id="O2" value="0.187" spread="0.137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.168" spread="0.128"/>
                    <measurement group_id="O2" value="0.211" spread="0.157"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.179" spread="0.131"/>
                    <measurement group_id="O2" value="0.229" spread="0.156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.193" spread="0.141"/>
                    <measurement group_id="O2" value="0.243" spread="0.160"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.161" spread="0.155"/>
                    <measurement group_id="O2" value="0.248" spread="0.172"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.175" spread="0.182"/>
                    <measurement group_id="O2" value="0.243" spread="0.181"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.119" spread="0.199"/>
                    <measurement group_id="O2" value="0.202" spread="0.191"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=30,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.145" spread="0.165"/>
                    <measurement group_id="O2" value="0.200" spread="0.203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.105" spread="0.167"/>
                    <measurement group_id="O2" value="0.148" spread="0.197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.193" spread="0.152"/>
                    <measurement group_id="O2" value="0.153" spread="0.211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.223" spread="0.148"/>
                    <measurement group_id="O2" value="0.151" spread="0.198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.232" spread="0.175"/>
                    <measurement group_id="O2" value="0.158" spread="0.229"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.184" spread="0.178"/>
                    <measurement group_id="O2" value="0.163" spread="0.237"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.132" spread="0.189"/>
                    <measurement group_id="O2" value="0.088" spread="0.211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.144" spread="0.161"/>
                    <measurement group_id="O2" value="0.120" spread="0.195"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent of Predicted Forced Expiratory Volume at One Second at Pre-dose and Each Assessed Time Point Post-Dose</title>
        <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function at specified time points.</description>
        <time_frame>Pre-dose, Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Predicted Forced Expiratory Volume at One Second at Pre-dose and Each Assessed Time Point Post-Dose</title>
          <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function at specified time points.</description>
          <population>Intent to treat population</population>
          <units>Percent of Predicted FEV1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40.717" spread="10.522"/>
                    <measurement group_id="O2" value="40.784" spread="10.554"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immediately post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.504" spread="10.938"/>
                    <measurement group_id="O2" value="46.396" spread="10.617"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 min post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.990" spread="10.407"/>
                    <measurement group_id="O2" value="47.303" spread="10.250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.456" spread="10.638"/>
                    <measurement group_id="O2" value="47.816" spread="10.469"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.136" spread="10.393"/>
                    <measurement group_id="O2" value="48.559" spread="10.352"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.839" spread="10.366"/>
                    <measurement group_id="O2" value="48.832" spread="9.868"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.294" spread="10.678"/>
                    <measurement group_id="O2" value="48.133" spread="10.958"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.534" spread="10.892"/>
                    <measurement group_id="O2" value="46.491" spread="10.507"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=31,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.913" spread="10.947"/>
                    <measurement group_id="O2" value="46.360" spread="10.932"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.885" spread="10.726"/>
                    <measurement group_id="O2" value="45.446" spread="10.821"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.935" spread="10.728"/>
                    <measurement group_id="O2" value="45.560" spread="11.216"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47.848" spread="10.703"/>
                    <measurement group_id="O2" value="45.723" spread="11.043"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48.051" spread="10.730"/>
                    <measurement group_id="O2" value="45.711" spread="11.116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46.977" spread="10.236"/>
                    <measurement group_id="O2" value="45.599" spread="11.074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.876" spread="11.561"/>
                    <measurement group_id="O2" value="42.793" spread="11.537"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44.844" spread="10.730"/>
                    <measurement group_id="O2" value="43.729" spread="11.178"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Percent of Predicted Forced Expiratory Volume at One Second (FEV1) at Each Assessed Time Point Post-Dose Compared to Pre-Dose</title>
        <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the change in percent of the estimated healthy lung function at specified time points compared to the pre-dose value.</description>
        <time_frame>Immediately post first dose, 30 min, 1,2,4,6,8,10,12,12.5,13,14,16,23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Percent of Predicted Forced Expiratory Volume at One Second (FEV1) at Each Assessed Time Point Post-Dose Compared to Pre-Dose</title>
          <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the change in percent of the estimated healthy lung function at specified time points compared to the pre-dose value.</description>
          <population>Intent to treat population</population>
          <units>percent of predicted FEV1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.787" spread="3.274"/>
                    <measurement group_id="O2" value="6.028" spread="4.296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.574" spread="3.880"/>
                    <measurement group_id="O2" value="6.917" spread="4.911"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.980" spread="4.124"/>
                    <measurement group_id="O2" value="7.437" spread="4.578"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.570" spread="4.607"/>
                    <measurement group_id="O2" value="8.055" spread="4.761"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.399" spread="4.820"/>
                    <measurement group_id="O2" value="8.189" spread="5.103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.576" spread="5.237"/>
                    <measurement group_id="O2" value="7.904" spread="5.786"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.816" spread="6.276"/>
                    <measurement group_id="O2" value="6.261" spread="6.101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=30,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.810" spread="5.710"/>
                    <measurement group_id="O2" value="6.130" spread="6.679"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.507" spread="5.382"/>
                    <measurement group_id="O2" value="4.662" spread="6.733"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.557" spread="5.216"/>
                    <measurement group_id="O2" value="4.776" spread="7.496"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.470" spread="4.903"/>
                    <measurement group_id="O2" value="4.939" spread="6.978"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.672" spread="5.398"/>
                    <measurement group_id="O2" value="4.927" spread="7.734"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.259" spread="5.767"/>
                    <measurement group_id="O2" value="4.937" spread="8.080"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.498" spread="6.276"/>
                    <measurement group_id="O2" value="2.457" spread="7.732"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.875" spread="4.925"/>
                    <measurement group_id="O2" value="3.528" spread="6.540"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Percent of Predicted Forced Expiratory Volume at One Second (FEV1) Over 12 Hours Post-Dose.</title>
        <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function and reports the highest percent found within 12 hours of dosing.</description>
        <time_frame>12 hours</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Percent of Predicted Forced Expiratory Volume at One Second (FEV1) Over 12 Hours Post-Dose.</title>
          <description>Predicted FEV1 is based on a formula using sex, age and height of a person, and is an estimate of healthy lung capacity. This outcome uses actual FEV1 readings to generate the percent of the estimated healthy lung function and reports the highest percent found within 12 hours of dosing.</description>
          <population>Intent to treat population</population>
          <units>percent of predicted FEV1</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.399" spread="10.738"/>
                    <measurement group_id="O2" value="51.251" spread="10.606"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.694</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>0.525</ci_lower_limit>
            <ci_upper_limit>2.862</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Peak Change in Forced Expiratory Volume at One Second (FEV1) Within 12 Hours Post Dose Compared to Pre-dose</title>
        <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 12 hours post-dose, and reports the largest change during that time.</description>
        <time_frame>12 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Peak Change in Forced Expiratory Volume at One Second (FEV1) Within 12 Hours Post Dose Compared to Pre-dose</title>
          <description>Forced Expiratory Volume in one second (FEV1) is the volume of air forcibly exhaled in one second as measured by a spirometer. This outcome measures the change in FEV1 from pre-dose to the readings taken 12 hours post-dose, and reports the largest change during that time.</description>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="32"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.269" spread="0.154"/>
                    <measurement group_id="O2" value="0.324" spread="0.166"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Equivalence was defined a priori such that 90%CI for the difference between therapies had to fall entirely within +/- 0.07L.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.052</param_value>
            <ci_percent>90</ci_percent>
            <ci_lower_limit>0.015</ci_lower_limit>
            <ci_upper_limit>0.090</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Onset of 15 Percent Response Within 12 Hours of Dosing</title>
        <description>Time to a 15 percent improvement in forced expiratory volume in one second (FEV1) within 12 hours of dosing. Only patients who achieved at least a 15 percent improvement are included.</description>
        <time_frame>12 hours post first dose</time_frame>
        <population>Intent to treat population. Limited to those patients who had a 15% response.</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Onset of 15 Percent Response Within 12 Hours of Dosing</title>
          <description>Time to a 15 percent improvement in forced expiratory volume in one second (FEV1) within 12 hours of dosing. Only patients who achieved at least a 15 percent improvement are included.</description>
          <population>Intent to treat population. Limited to those patients who had a 15% response.</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.75" lower_limit="1.26" upper_limit="111.28"/>
                    <measurement group_id="O2" value="2.43" lower_limit="1.13" upper_limit="692.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase Within 12 Hours of Dosing</title>
        <description>Time to a 12 percent improvement in forced expiratory volume in one second (FEV1) AND a 200 milliliter increase in FEV1 within 12 hours of dosing. Only patients who met both conditions are included</description>
        <time_frame>up to 12 hours post dose</time_frame>
        <population>Intent to treat population. Limited to patients who met both criteria: a 12 percent increase in FEV1 and a 200 milliliter increase in FEV1</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase Within 12 Hours of Dosing</title>
          <description>Time to a 12 percent improvement in forced expiratory volume in one second (FEV1) AND a 200 milliliter increase in FEV1 within 12 hours of dosing. Only patients who met both conditions are included</description>
          <population>Intent to treat population. Limited to patients who met both criteria: a 12 percent increase in FEV1 and a 200 milliliter increase in FEV1</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.62" lower_limit="1.22" upper_limit="343.91"/>
                    <measurement group_id="O2" value="2.86" lower_limit="1.22" upper_limit="595.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase in Forced Expiratory Volume in One Second Within 12 Hours of Dosing</title>
        <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration.</description>
        <time_frame>pre-dose, immediately post first dose, 30 min, 1,2,4,6,8,10,12, 12.5, 13, 14, 16, 23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Onset of Response of Both a 12 Percent Increase and 200 Milliliter Increase in Forced Expiratory Volume in One Second Within 12 Hours of Dosing</title>
          <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration.</description>
          <population>Intent to treat population</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pre-dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.545" spread="0.718"/>
                    <measurement group_id="O2" value="2.601" spread="0.746"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Immediately post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.838" spread="0.790"/>
                    <measurement group_id="O2" value="2.905" spread="0.796"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.903" spread="0.814"/>
                    <measurement group_id="O2" value="2.953" spread="0.808"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.918" spread="0.771"/>
                    <measurement group_id="O2" value="3.003" spread="0.846"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.931" spread="0.804"/>
                    <measurement group_id="O2" value="3.030" spread="0.800"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=33,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.871" spread="0.783"/>
                    <measurement group_id="O2" value="3.028" spread="0.849"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.849" spread="0.822"/>
                    <measurement group_id="O2" value="2.993" spread="0.844"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.776" spread="0.828"/>
                    <measurement group_id="O2" value="2.940" spread="0.850"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=31,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.796" spread="0.852"/>
                    <measurement group_id="O2" value="2.906" spread="0.910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.702" spread="0.832"/>
                    <measurement group_id="O2" value="2.797" spread="0.862"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.852" spread="0.832"/>
                    <measurement group_id="O2" value="2.796" spread="0.852"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.905" spread="0.876"/>
                    <measurement group_id="O2" value="2.815" spread="0.829"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.878" spread="0.839"/>
                    <measurement group_id="O2" value="2.813" spread="0.862"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (n=32,33)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.854" spread="0.824"/>
                    <measurement group_id="O2" value="2.812" spread="0.869"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.733" spread="0.834"/>
                    <measurement group_id="O2" value="2.700" spread="0.866"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.774" spread="0.809"/>
                    <measurement group_id="O2" value="2.763" spread="0.875"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Forced Vital Capacity From Pre-dose to Each Post-Dose Assessed Time Point</title>
        <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration. The measure compares the change from pre-dose reading to each post-dose time point.</description>
        <time_frame>immediately post first dose, 30 min, 1,2,4,6,8,10,12, 12.5, 13, 14, 16, 23,24 hours post first dose</time_frame>
        <population>Intent to treat population</population>
        <group_list>
          <group group_id="O1">
            <title>15 Mcg BID</title>
            <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
          </group>
          <group group_id="O2">
            <title>30 Mcg QD</title>
            <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Forced Vital Capacity From Pre-dose to Each Post-Dose Assessed Time Point</title>
          <description>Forced vital capacity is the total amount of air that can forcibly be blown out after full inspiration. The measure compares the change from pre-dose reading to each post-dose time point.</description>
          <population>Intent to treat population</population>
          <units>liters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Immediately post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.293" spread="0.240"/>
                    <measurement group_id="O2" value="0.290" spread="0.274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>30 minutes post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.334" spread="0.264"/>
                    <measurement group_id="O2" value="0.340" spread="0.274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 hour post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.352" spread="0.270"/>
                    <measurement group_id="O2" value="0.390" spread="0.310"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.355" spread="0.277"/>
                    <measurement group_id="O2" value="0.411" spread="0.335"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.296" spread="0.308"/>
                    <measurement group_id="O2" value="0.398" spread="0.369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.304" spread="0.331"/>
                    <measurement group_id="O2" value="0.384" spread="0.364"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>8 hours post first dose (n=32,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.231" spread="0.352"/>
                    <measurement group_id="O2" value="0.331" spread="0.393"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>10 hours post first dose (n=30,30)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.246" spread="0.345"/>
                    <measurement group_id="O2" value="0.297" spread="0.386"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.175" spread="0.319"/>
                    <measurement group_id="O2" value="0.196" spread="0.359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12.5 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.325" spread="0.348"/>
                    <measurement group_id="O2" value="0.195" spread="0.355"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>13 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.378" spread="0.326"/>
                    <measurement group_id="O2" value="0.214" spread="0.359"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>14 hours post first dose (n=30,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.351" spread="0.374"/>
                    <measurement group_id="O2" value="0.213" spread="0.383"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>16 hours post first dose (n=32,32)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.308" spread="0.378"/>
                    <measurement group_id="O2" value="0.183" spread="0.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>23 hours post first dose (n=30,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.206" spread="0.348"/>
                    <measurement group_id="O2" value="0.088" spread="0.380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 hours post first dose (n=31,31)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.257" spread="0.337"/>
                    <measurement group_id="O2" value="0.148" spread="0.344"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>Total number of participants in study is 33. 33 particpants at risk in each treatment arm due to cross over study design.</desc>
      <group_list>
        <group group_id="E1">
          <title>15 Mcg BID</title>
          <description>Arformoterol 15 mcg twice a day (morning and evening)</description>
        </group>
        <group group_id="E2">
          <title>30 Mcg QD</title>
          <description>Arformoterol 30 mcg once a day (morning) and placebo (evening)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA 10.1</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Viral Upper Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthraglia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>In addition to the 60 to 180 day restriction above, since this is a multicenter study, first publication of study results shall be made with other participating study sites as a multicenter publication; provided, if a multicenter publication is not forthcoming within 24 months following completion of study at all sites, the PI shall be free to publish</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single day/dose; small numbers of subjects; difference between arms (2mL vs 4mL per dose); Predefined +/-0.07L equivalence is arbitrarily lower than the clinically recognized 0.1L. Hence, clinical efficacy &amp; safety conclusions are difficult to reach.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Brovana Medical Director</name_or_title>
      <organization>Sunovion</organization>
      <phone>1-866-503-6351</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

